Introduction to Retatrutide
Retatrutide is a synthetic peptide currently under investigation as a triple hormone receptor agonist, targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This unique mechanism of action positions it as a compound of significant interest in metabolic research.
Mechanism of Action
As a GLP-1/GIP receptor agonist, Retatrutide activates multiple pathways involved in energy homeostasis. Laboratory studies suggest that simultaneous activation of these receptors may influence glucose metabolism, insulin sensitivity, and energy expenditure. The addition of glucagon receptor agonism introduces a thermogenic component that distinguishes it from dual GLP-1/GIP agonists.
Research Applications
Current investigations focus on Retatrutide’s potential effects on metabolic regulation, including its thermogenic properties and impact on body composition. Researchers are particularly interested in its ability to modulate energy balance through multiple physiological pathways simultaneously.
Product Availability
Retatrutide is available for research purposes in the following formats:
- Retatrutide 5mg – Standard dosage for laboratory studies
- Retatrutide 10mg – Higher concentration for extended research protocols
All products are intended for laboratory research use only and are not for human consumption.